This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, L L Search for Related Content PubMed PubMed Citation Articles by Johnson, L L

 Previous Article  |  Next Article 

Infect Immun. 1992 September; 60(9): 3719-3724

SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections.

Trudeau Institute, Inc., Saranac Lake, New York 12983.

ABSTRACT

Lymphodeficient scid/scid (SCID) mice died from acute infection with a strain of Toxoplasma gondii that causes chronic infection with mild symptoms in immunocompetent non-SCID mice. However, most SCID mice reconstituted with spleen cells from immunocompetent mice 1 month prior to T. gondii infection survived in good health after a transient period during which they appeared ill. Unreconstituted SCID mice given sulfadiazine in their drinking water from day 10 of Toxoplasma infection onward survived the acute phase of infection and lived for many weeks without overt symptoms. Histological examination revealed Toxoplasma cysts in their brains. However, if sulfadiazine was withdrawn from the drinking water of these chronically infected SCID mice, the mice died within 1 week with large numbers of trophozoites throughout their brains. These findings establish SCID mice as a potentially useful resource with which to study various aspects of immunological control of T. gondii infection during either its acute or chronic phase. Furthermore, the ability to produce chronic infections with avirulent T. gondii in SCID mice and to cause acute relapsing infections at will suggests that SCID mice may be helpful in evaluating potential therapies for acute and chronic T. gondii infections in immunocompromised patients.

This article has been cited by other articles:

• Subauste, C. S., Wessendarp, M. (2006). CD40 Restrains In Vivo Growth of Toxoplasma gondii Independently of Gamma Interferon. Infect. Immun. 74: 1573-1579 [Abstract] [Full Text]  
• Couper, K. N., Roberts, C. W., Brombacher, F., Alexander, J., Johnson, L. L. (2005). Toxoplasma gondii-Specific Immunoglobulin M Limits Parasite Dissemination by Preventing Host Cell Invasion. Infect. Immun. 73: 8060-8068 [Abstract] [Full Text]  
• Combe, C. L., Curiel, T. J., Moretto, M. M., Khan, I. A. (2005). NK Cells Help To Induce CD8+-T-Cell Immunity against Toxoplasma gondii in the Absence of CD4+ T Cells. Infect. Immun. 73: 4913-4921 [Abstract] [Full Text]  
• Smiley, S. T., Lanthier, P. A., Couper, K. N., Szaba, F. M., Boyson, J. E., Chen, W., Johnson, L. L. (2005). Exacerbated Susceptibility to Infection-Stimulated Immunopathology in CD1d-Deficient Mice. J. Immunol. 174: 7904-7911 [Abstract] [Full Text]  
• Pepper, M., Dzierszinski, F., Crawford, A., Hunter, C. A., Roos, D. (2004). Development of a System To Study CD4+-T-Cell Responses to Transgenic Ovalbumin-Expressing Toxoplasma gondii during Toxoplasmosis. Infect. Immun. 72: 7240-7246 [Abstract] [Full Text]  
• Casciotti, L., Ely, K. H., Williams, M. E., Khan, I. A. (2002). CD8+-T-Cell Immunity against Toxoplasma gondii Can Be Induced but Not Maintained in Mice Lacking Conventional CD4+ T Cells. Infect. Immun. 70: 434-443 [Abstract] [Full Text]  
• Khan, I. A., Murphy, P. M., Casciotti, L., Schwartzman, J. D., Collins, J., Gao, J.-L., Yeaman, G. R. (2001). Mice Lacking the Chemokine Receptor CCR1 Show Increased Susceptibility to Toxoplasma gondii Infection. J. Immunol. 166: 1930-1937 [Abstract] [Full Text]  
• Khan, I. A., Casciotti, L. (1999). IL-15 Prolongs the Duration of CD8+ T Cell-Mediated Immunity in Mice Infected with a Vaccine Strain of Toxoplasma gondii. J. Immunol. 163: 4503-4509 [Abstract] [Full Text]